Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines

Margaret A. Tempero; Mokenge P. Malafa; E. Gabriela Chiorean; Brian Czito; Courtney Scaife; Amol K. Narang; Christos Fountzilas; Brian M. Wolpin; Mahmoud Al-Hawary; Horacio Asbun; Stephen W. Behrman; Al B. Benson; Ellen Binder; Dana B. Cardin; Charles Cha; Vincent Chung; Mary Dillhoff; Efrat Dotan; Cristina R. Ferrone; George Fisher; Jeffrey Hardacre; William G. Hawkins; Andrew H. Ko; Noelle LoConte; Andrew M. Lowy; Cassadie Moravek; Eric K. Nakakura; Eileen M. O’Reilly; Jorge Obando; Sushanth Reddy; Sarah Thayer; Robert A. Wolff; Jennifer L. Burns; Griselda Zuccarino-Catania

doi:10.6004/jnccn.2019.0014

Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines

Margaret A. Tempero, Mokenge P. Malafa, E. Gabriela Chiorean, Brian Czito, Courtney Scaife, Amol K. Narang, Christos Fountzilas, Brian M. Wolpin, Mahmoud Al-Hawary, Horacio Asbun, Stephen W. Behrman, Al B. Benson, Ellen Binder, Dana B. Cardin, Charles Cha, Vincent Chung, Mary Dillhoff, Efrat Dotan, Cristina R. Ferrone, George FisherJeffrey Hardacre, William G. Hawkins, Andrew H. Ko, Noelle LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Eileen M. O’Reilly, Jorge Obando, Sushanth Reddy, Sarah Thayer, Robert A. Wolff, Jennifer L. Burns, Griselda Zuccarino-Catania

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

319 Scopus citations

Abstract

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

Original language	English (US)
Pages (from-to)	203-210
Number of pages	8
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	17
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2019.0014
State	Published - Mar 2019

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2019.0014

Cite this

Tempero, M. A., Malafa, M. P., Chiorean, E. G., Czito, B., Scaife, C., Narang, A. K., Fountzilas, C., Wolpin, B. M., Al-Hawary, M., Asbun, H., Behrman, S. W., Benson, A. B., Binder, E., Cardin, D. B., Cha, C., Chung, V., Dillhoff, M., Dotan, E., Ferrone, C. R., ... Zuccarino-Catania, G. (2019). Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 17(3), 203-210. https://doi.org/10.6004/jnccn.2019.0014

@article{b9e0ac2f61ae42029d99dadcb2217311,

title = "Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.",

author = "Tempero, {Margaret A.} and Malafa, {Mokenge P.} and Chiorean, {E. Gabriela} and Brian Czito and Courtney Scaife and Narang, {Amol K.} and Christos Fountzilas and Wolpin, {Brian M.} and Mahmoud Al-Hawary and Horacio Asbun and Behrman, {Stephen W.} and Benson, {Al B.} and Ellen Binder and Cardin, {Dana B.} and Charles Cha and Vincent Chung and Mary Dillhoff and Efrat Dotan and Ferrone, {Cristina R.} and George Fisher and Jeffrey Hardacre and Hawkins, {William G.} and Ko, {Andrew H.} and Noelle LoConte and Lowy, {Andrew M.} and Cassadie Moravek and Nakakura, {Eric K.} and O{\textquoteright}Reilly, {Eileen M.} and Jorge Obando and Sushanth Reddy and Sarah Thayer and Wolff, {Robert A.} and Burns, {Jennifer L.} and Griselda Zuccarino-Catania",

year = "2019",

month = mar,

doi = "10.6004/jnccn.2019.0014",

language = "English (US)",

volume = "17",

pages = "203--210",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "3",

}

Tempero, MA, Malafa, MP, Chiorean, EG, Czito, B, Scaife, C, Narang, AK, Fountzilas, C, Wolpin, BM, Al-Hawary, M, Asbun, H, Behrman, SW, Benson, AB, Binder, E, Cardin, DB, Cha, C, Chung, V, Dillhoff, M, Dotan, E, Ferrone, CR, Fisher, G, Hardacre, J, Hawkins, WG, Ko, AH, LoConte, N, Lowy, AM, Moravek, C, Nakakura, EK, O’Reilly, EM, Obando, J, Reddy, S, Thayer, S, Wolff, RA, Burns, JL & Zuccarino-Catania, G 2019, 'Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 3, pp. 203-210. https://doi.org/10.6004/jnccn.2019.0014

TY - JOUR

T1 - Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines

AU - Tempero, Margaret A.

AU - Malafa, Mokenge P.

AU - Chiorean, E. Gabriela

AU - Czito, Brian

AU - Scaife, Courtney

AU - Narang, Amol K.

AU - Fountzilas, Christos

AU - Wolpin, Brian M.

AU - Al-Hawary, Mahmoud

AU - Asbun, Horacio

AU - Behrman, Stephen W.

AU - Benson, Al B.

AU - Binder, Ellen

AU - Cardin, Dana B.

AU - Cha, Charles

AU - Chung, Vincent

AU - Dillhoff, Mary

AU - Dotan, Efrat

AU - Ferrone, Cristina R.

AU - Fisher, George

AU - Hardacre, Jeffrey

AU - Hawkins, William G.

AU - Ko, Andrew H.

AU - LoConte, Noelle

AU - Lowy, Andrew M.

AU - Moravek, Cassadie

AU - Nakakura, Eric K.

AU - O’Reilly, Eileen M.

AU - Obando, Jorge

AU - Reddy, Sushanth

AU - Thayer, Sarah

AU - Wolff, Robert A.

AU - Burns, Jennifer L.

AU - Zuccarino-Catania, Griselda

PY - 2019/3

Y1 - 2019/3

N2 - The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

AB - The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

UR - http://www.scopus.com/inward/record.url?scp=85062850662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062850662&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2019.0014

DO - 10.6004/jnccn.2019.0014

M3 - Article

C2 - 30865919

AN - SCOPUS:85062850662

SN - 1540-1405

VL - 17

SP - 203

EP - 210

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this